Sort

Search

01/01/2024 Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.
Rodríguez-Padial L, Pérez A, Anguita Sánchez M, Barrios V, Gimeno-Orna JA, Muñiz J. Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.. Cardiology Journal. 2024; 31(1)DOI:10.5603/CJ.a2023.0016. PMID:36896635. IF:1.900(Q3/6D).
01/01/2024 Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
García MJ, Rivero M, Fernández-Clotet A, de Francisco R, Sicilia B, Mesonero F, de Castro ML, Casanova MJ, Bertoletti F, García-Alonso FJ, López-García A, Vicente R, Calvet X, Barreiro-de Acosta M, Ferrer Rosique J, Varela Trastoy P, Nuñez A, Ricart E, Riestra S, Arias García L, Rodríguez M, Arranz L, Pajares R, Mena R, Calafat M, Camo P, Bermejo F, Ponferrada Á, Madrigal RE, Llaó J, Sesé E, Sánchez E, Pineda Mariño JR, González Muñoza C, Carbajo López AY, Julián AB, Villoria Ferrer A, Baston-Rey I, Jara L, Almela P, Codesido L, de la Maza S, Leal C, Caballol B, Pérez-Martínez I, Vinuesa Campo R, Crespo J, Domènech E, Chaparro M, Gisbert JP. Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.. Journal of Crohns & Colitis. 2024; 18(1)DOI:10.1093/ecco-jcc/jjad124. PMID:37522878. IF:8.700(Q1/1D).
01/01/2024 Long-Term Results of Cortical Motor Stimulation for Neuropathic Peripheral and Central Pain: Real-World Evidence From Two Independent Centers.
Aibar-Durán JÁ, Villalba Martínez G, Freixer-Palau B, Araus-Galdós E, Morollón Sanchez-Mateos N, Belvis Nieto R, Revuelta Rizo M, Molet Teixeido J, García Sánchez C, de Quintana Schmidt C, Muñoz Hernandez F, Rodríguez Rodríguez R. Long-Term Results of Cortical Motor Stimulation for Neuropathic Peripheral and Central Pain: Real-World Evidence From Two Independent Centers.. Neurosurgery. 2024; 94(1)DOI:10.1227/neu.0000000000002638. PMID:37638720. IF:3.900(Q1/1D).
01/01/2024 Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders.
Cardoner N, Andero R, Cano M, Marin-Blasco I, Porta-Casteràs D, Serra-Blasco M, Via E, Vicent-Gil M, Portella M. Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders.. Current Neuropharmacology. 2024; 22(5)DOI:10.2174/1570159X21666230703091435. PMID:37403395. IF:5.300(Q1/2D).